Pages
Meet Barbara: 71-year-old nurse and role model
https://dchs.nhs.uk/news/meet-barbara-71-year-old-nurse-and-role-model
DCHS Charitable Fund Restructure
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/dchs-charitable-fund-restructure
World AIDS Day reminds us of importance of early testing
https://dchs.nhs.uk/news/world-aids-day-reminds-us-importance-early-testing
Pulse Survey results – quarter two
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/pulse-survey-results-quarter-two
Staff networks for equality diversity and inclusion
The LGBT+ staff network, BAME staff network, disability and long term conditions DLTC staff network and armed forces staff network
https://dchs.nhs.uk/about-us/equality-diversity-inclusion/staff-networks
Files
Appendix 7 – Work Placement Candidate Placement Plan.docx
Appendix 7 – Work Placement Candidate Placement Plan
The-DCHS-Clinical-strategy-Final-Version-3rd-June.pdf
DCHS Clinical Strategy 2019-2020
Covert Administration of Medicines Policy (P59)
The policy applies to patients who are being treated by Derbyshire Community Health Services Foundation Trust (DCHSFT) inpatient wards, units and pathway 2 care home beds where DCHS employed staff have medical accountability for residents. DCHSFT recognises and respects the autonomy of individuals who receive treatment. However there are times when severely incapacitated individuals in our care can neither consent nor refuse treatment and the use of covert medications may need to be considered. This policy applies to the administration of medicines for a physical disorder or a mental disorder under the Mental Capacity Act 2005 and to medication for a mental disorder administered under Part 4 and Part 4A of the Mental Health Act 1983. Treatment of a physical condition can only be given under the Mental Health Act Part 4 if the condition is a symptom or manifestation of the mental disorder.
SOP for IV Administration of Diuretics to Heart Failure Patients in DCHS North Community Hospitals and CRH Same Day ECU (S89)
The Aim of this SOP is to provide heart failure patients across Derbyshire access to IV drug treatments without the need for attendance at an acute hospital
SOP For use of HoverMatt and HoverJack for lateral transfers by community staff (S78)
This standard operating procedure sets out the process by which clinicians working within Community Services access and use the HoverMatt & HoverJack for lateral transfer of patients in a community setting.
Vaccination programme (flexible staffing and bank) - Employee Online user guide.pdf
Driver Delivering Flu Vaccines - Standing Operating procedure for the flu campaign (S116)
Standing Operating procedure for the flu campaign September 2023
HRP02 Secondary Employment Policy Appendix B Working Time Regulation Opt Out Form.docx
HRP02 Secondary Employment Policy - Appendix B Working Time Regulation Opt Out Form
Appendix 7 - Flexible Working Pattern Confirmation Letter.docx
Appendix 7 - Flexible Working Pattern Confirmation Letter
Administration of Insulin Injection Policy and Standard Operating Procedure (P4)
There are a growing number of people who, because of disability, increasing age or infirmity, are unable to administer their own insulin and will need support. This guideline aims to promote standardisation and safety of insulin administration within Derbyshire Community Health Services (DCHS NHS FT). This document aligns with the Professional Guidance on the Administration of Medicines in Healthcare Settings (Royal Pharmaceutical Society 2019). Patient centred care based upon different ways of working underpins this policy and procedure as identified within the NHS Plan (DH 2000), the NSF for Older People (DH 2001), Making a Difference (DH 2001) and the NSF for Diabetes (DH 2002). UK Injection technique Recommendations have been considered alongside the need to consider safer sharps for staff (Forum for Injection Technique 2016). Underpinning the guidance are the most recent NICE and Derbyshire guidance for the management of diabetes (Joint Area Prescribing Committee 2018 NICE 2015) and National Patient Safety Alert (NPSA), ‘Risk of severe harm and death due to withdrawing insulin from pen devices,’ 16 November 2016.